NGS-guided assessment of interactions between tumors and the immune system leads to new discoveries in immuno-oncology. Introduction Traditionally the…
Did you attend the 2nd Annual Advances in Immuno-Oncology Congress this year? In this conference report find out more about the successes of the event and find out how you can attend the event next year.
As part of our recent Spotlight focus on biosimilars in oncology, we asked you to share your thoughts and opinions on the role of biosimilars in oncology. Thanks to all who shared your thoughts with us – the results have been translated into this summary infographic.
In this infographic gain a visual snapshot of a review article in which over 50 leaders in the dermatology field critically assess current screening practice for melanoma in an effort to propose rational, risk-based, data-driven guidelines for skin cancer screening.
This report outlines the clinically led development of UK-focused guidance to challenge psycho-oncology services to achieve and demonstrate their potential.
To mark Triple-Negative Breast Cancer Day, take a look at our new and exclusive summary infographic presenting some of the key facts about triple-negative breast cancer.
Following the continuing evolution of cancer immunotherapy, this featured article discusses how image-guided, minimally invasive therapies and immuno-oncology agents may be combined – could there be resultant synergy between these two modalities?
This exclusive opinion piece debates the use of therapeutic agents already established for other conditions for the treatment of cancer.